Literature DB >> 10380350

From natural to synthetic multisite thrombin inhibitors.

A Lombardi1, G De Simone, S Galdiero, N Staiano, F Nastri, V Pavone.   

Abstract

A large number of potent and selective therapeutic agents, useful for the treatment of several diseases, have been isolated from natural sources. For example, the most active thrombin inhibitors are those secreted by the salivary glands of leeches. One peculiar feature of these agents is the lack of any significant inhibitory cross-reaction with other serine proteinases. Hence, the knowledge of the exact mechanism of action of these molecules provides the basis for the development of new and efficient synthetic drugs. For this reason, many studies have been undertaken on the structure-activity relationships of natural thrombin inhibitors, and a large amount of detailed information has been obtained by the crystal structures of these inhibitors when complexed with thrombin. In this paper, we review natural and synthetic multisite thrombin inhibitors, whose structural aspects have been determined in detail. We also report here the approach used by us to develop a new class of synthetic, multisite directed thrombin inhibitors, named hirunorms, designed to mimic the distinctive binding mode of hirudin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380350     DOI: 10.1002/(SICI)1097-0282(1999)51:1<19::AID-BIP4>3.0.CO;2-G

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  7 in total

1.  Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.

Authors:  J L Richardson; B Kröger; W Hoeffken; J E Sadler; P Pereira; R Huber; W Bode; P Fuentes-Prior
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

3.  Proton bridging in the interactions of thrombin with small inhibitors.

Authors:  Ildiko M Kovach; Paul Kelley; Carol Eddy; Frank Jordan; Ahmet Baykal
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

4.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

Review 5.  Proton Bridging in Catalysis by and Inhibition of Serine Proteases of the Blood Cascade System.

Authors:  Ildiko M Kovach
Journal:  Life (Basel)       Date:  2021-04-27

6.  Modifying the substrate specificity of Carcinoscorpius rotundicauda serine protease inhibitor domain 1 to target thrombin.

Authors:  Pankaj Kumar Giri; Xuhua Tang; Saravanan Thangamani; Rajesh T Shenoy; Jeak Ling Ding; Kunchithapadam Swaminathan; J Sivaraman
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

7.  Aptamer-functionalized nano-biosensors.

Authors:  Tai-Chia Chiu; Chih-Ching Huang
Journal:  Sensors (Basel)       Date:  2009-12-21       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.